Antipsychotic Drugs and Risk of Hip Fracture in People Aged 60 and Older in Norway
Authors:
- 20 June 2016
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 64 (6) , 1203-1209
Abstract
Objectives: To examine associations between exposure to various subgroups of antipsychotic drugs and risk of hip fracture in older adults. Design: Nationwide cohort study. Setting: Norway, 2005–2010. Participants: Everyone living in Norway born before 1945 (N = 906,422). Measurements: Information was obtained on all prescriptions of antipsychotic drugs dispensed from 2004 to 2010 (Norwegian Prescription Database) and data on all primary hip fractures from 2005 to 2010 (Norwegian Hip Fracture Registry). Incidence rates of hip fracture during person‐time exposed and unexposed to antipsychotic drugs were compared by calculating the standardized incidence ratio ( SIR ). Results: Thirty‐nine thousand nine hundred thirty‐eight (4.4%) participants experienced a primary hip fracture. Greater risk of hip fracture was associated with exposure to any antipsychotic ( SIR = 2.1, 95% confidence interval ( CI ) = 1.9–2.1), first‐generation antipsychotics ( SIR = 2.0, 95% CI = 1.8–2.2), second‐generation antipsychotics ( SIR = 2.2, 95% CI = 1.9–2.4), prolactin‐sparing antipsychotics ( SIR = 2.4, 95% CI = 1.8–3.1) and prolactin‐elevating antipsychotics ( SIR = 2.0, 95% CI = 1.9–2.2). Conclusion: In people aged 60 and older in Norway, those who took an antipsychotic drug had twice the risk of sustaining a hip fracture during exposure than during nonexposure. Although confounding by indication, comorbidity, or other drugs used cannot be excluded, this association is relevant for clinical practice because hip fracture and antipsychotic drug use are prevalent in vulnerable older individuals. Clinical studies examining mechanisms or causality of the observed association between antipsychotic drug use and excess risk of hip fracture are needed.Keywords
This publication has 39 references indexed in Scilit:
- Possible mechanisms for the skeletal effects of antipsychotics in children and adolescentsTherapeutic Advances in Psychopharmacology, 2013
- Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery?Schizophrenia Bulletin, 2013
- Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohortsInternational Journal of Geriatric Psychiatry, 2012
- Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic reviewBMC Medical Research Methodology, 2012
- Risk of Hospitalization for Hip Fracture and Pneumonia Associated with Antipsychotic Prescribing in the ElderlyDrug Safety, 2011
- Update in Serotonin and BoneThe Journal of Clinical Endocrinology & Metabolism, 2010
- The cost of hemiarthroplasty compared to that of internal fixation for femoral neck fracturesActa Orthopaedica, 2010
- Validity of the Finnish Prescription Register for Measuring Psychotropic Drug Exposures among Elderly FinnsDrugs & Aging, 2010
- Antipsychotic use and the risk of hip/femur fracture: a population-based case–control studyOsteoporosis International, 2009
- Cortical Dopamine D2/D3 Receptors Are a Common Site of Action for Antipsychotic Drugs--An Original Patient Data Meta-analysis of the SPECT and PET In Vivo Receptor Imaging LiteratureSchizophrenia Bulletin, 2008